Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality

The rising cost of pharmaceutical expenditure in many European countries is of concern to governments required to make effective use of health care budgets.

Taking a broad perspective that encompasses the institutional, political and supranational aspects of pharmaceutical regulation, this book examines the approaches used to manage pharmaceutical expenditure across Europe and what impact they have had on the efficiency, equity, quality and cost of pharmaceutical care.